<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
><channel><title>Коментари на: Pismo zdravstvenim radnicima: rizik kod primene inhibitora natrijum-glukoznog kotransportera 2 (SGLT2)</title><atom:link href="http://mediscopia.com/pismo-zdravstvenim-radnicima-rizik-kod-primene-inhibitora-natrijum-glukoznog-kotransportera-2-sglt2/feed/" rel="self" type="application/rss+xml" /><link>http://mediscopia.com/pismo-zdravstvenim-radnicima-rizik-kod-primene-inhibitora-natrijum-glukoznog-kotransportera-2-sglt2/</link><description>Za stručnu medicinsku javnost</description><lastBuildDate>Thu, 11 Apr 2019 18:02:08 +0000</lastBuildDate><sy:updatePeriod>hourly</sy:updatePeriod><sy:updateFrequency>1</sy:updateFrequency><generator>https://wordpress.org/?v=7.1.3</generator></channel></rss>